Two of our patients with cerebral and CC atrophy underwent cognitive testing and showed signs of cognitive impairment suggesting a potential role of rare heterozygous SPG7 variants in the ALS-FTD disease spectrum. This evidence concerns the gene SPG7 and Cognitive impairment.